Sarcoma

Top Story

Eight noteworthy FDA actions

April 21, 2017

The FDA announced several decisions related to hematology and oncology therapies and devices in the past month.

HemOnc Today summarizes eight FDA actions that may be relevant to your practice.

In the Journals Plus

Men with HIV, nonmelanoma skin cancer at greater risk for Kaposi’s sarcoma

April 18, 2017
Men with HIV and nonmelanoma skin cancer faced an elevated risk for Kaposi’s sarcoma, as did men with HIV who lived in locations with high levels of ambient
Meeting News

Ten takeaways from the AACR Annual Meeting

April 14, 2017
This year’s American Association for Cancer Research Annual Meeting — titled “Research Propelling Cancer Prevention and Cures” — featured…

Patient education pivotal when recommending palliative care

April 12, 2017
Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment, according to results of a…
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Video
Meeting News Coverage

VIDEO: Developing targeted therapy for sarcoma remains a challenge

June 13, 2016
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »

Eight noteworthy FDA actions

April 21, 2017
The FDA announced several decisions related to hematology and oncology therapies and devices in the past month. HemOnc Today summarizes…

In the Journals Plus

Men with HIV, nonmelanoma skin cancer at greater risk for Kaposi’s sarcoma

April 18, 2017
Men with HIV and nonmelanoma skin cancer faced an elevated risk for Kaposi’s sarcoma, as did men with HIV who lived in locations with high

Meeting News

Ten takeaways from the AACR Annual Meeting

April 14, 2017
This year’s American Association for Cancer Research Annual Meeting — titled “Research Propelling Cancer Prevention and…

Patient education pivotal when recommending palliative care

April 12, 2017
Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment…

FDA News

FDA grants orphan drug designation to ganitumab for Ewing sarcoma

April 10, 2017
The FDA granted orphan drug designation to ganitumab for the treatment of Ewing sarcoma, according to the drug’s manufacturer. “We are…

In the Journals Plus

Physician-aided deaths continue to rise in Oregon

April 6, 2017
The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death…

In the Journals Plus

ASCO: Coordinated effort needed to provide high-quality care to sexual and gender minorities

April 5, 2017
Sexual and gender minorities diagnosed with cancer may encounter specific challenges, including discrimination and greater risks for anxiety and…

Meeting NewsPerspective

Incidence of certain cancers expected to decline among HIV–positive individuals

April 5, 2017
The burden of cancer in HIV–positive patients is projected to decrease by 2030, mostly driven by declines in non-Hodgkin lymphoma and Kaposi…

FDA News

FDA grants orphan drug designation to Yeliva for cholangiocarcinoma

April 4, 2017
The FDA granted orphan drug designation to Yeliva for the treatment of cholangiocarcinoma, according to the drug’s manufacturer. Yeliva…

Meeting News

Biden: Cancer moonshot has ‘evolved from program to movement’

April 3, 2017
International and private sector collaboration, as well as the $1.8 billion in federal funding directed toward the NIH as part of the 21st Century…

More Headlines »
Advertisement
Advertisement